Bridgefront Capital »

Silverback Therapeutics shares owned by Bridgefront Capital

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Bridgefront Capital from 13F filings

Historical chart of Bridgefront Capital investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Bridgefront Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $104k 13k 8.03

More positions owned by Bridgefront Capital

Take-Two Interactive Software (TTWO)
TPG Com Cl A (TPG)
Constellation Brands Cl A (STZ)
Broadcom (AVGO)
Encana Corporation (OVV)
Kimberly-Clark Corporation (KMB)
Clorox Company (CLX)
Lamb Weston Hldgs (LW)
Keysight Technologies (KEYS)
EQT Corporation (EQT)
Celsius Hldgs Com New (CELH)
Amgen (AMGN)
Micron Technology (MU)
Host Hotels & Resorts (HST)
Agree Realty Corporation (ADC)

View all positions for Bridgefront Capital

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Rubric Capital Management
Deerfield Management Company
Millennium Management
BlackRock
Standard Life Aberdeen
Sr One Capital Management
State Street Corporation
Franklin Resources
Tyro Capital Management
Vanguard Capital Management
UBS Group
Janney Montgomery Scott
Citadel Advisors

View all funds holding Silverback Therapeutics